New York, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Neurotech Devices: Global Market Outlook" - https://www.reportlinker ...
ARLINGTON, Va.--(BUSINESS WIRE)--At CES, AI is everywhere — it’s the buzzword at every booth and in every pitch. But beyond the flashy demos, what does AI truly mean for brands right now? Modev will ...
Dublin, Feb. 14, 2023 (GLOBE NEWSWIRE) -- The "Neurotech Devices: Global Market Outlook" report has been added to ResearchAndMarkets.com's offering. In this report, the market is segmented based on ...
Partnerships aim to support clinical, regulatory development, manufacturing and future market launches of NTI164 Neurotech to pursue multiple registrations of NTI164 in Australia, including leveraging ...
New York, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report 'Neurotech Devices: Global Market Outlook' - With 2021 as the base year, the report provides estimated ...
Neurotech will focus on global strategic partnerships for its broad-spectrum cannabinoid drug NTI164 to advance its path to commercialisation. Neurotech (ASX:NTI) says it’s working on securing one or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results